[Pharmacology in automobile driving and medical practice. II. Euhypnotic effect of Elenium and psychomotor efficiency in humans].
Explore the source record for details and available documents.
SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Sixteen post-stroke, hemiplegic patients, who requested that they be allowed to return to driving, were extensively evaluated by a physiatrist, psychologist, occupational therapist, and driver training specialist. After they completed a driver training program, the patients were divided into three groups based on their driving program success and follow-ups. Significant differences in the psychological test results were found between Group I (those who drove without any difficulty) and Groups II and III (those who drove limited distance or who failed driver training). Results suggest that patients with significant cognitive and perceptual problems who take training and limit their driving can be safe drivers when they return to driving.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Visual function is crucial in driving and is one of the links which determine the medical aptitude to this activity. The ophthalmologist has important medical and moral responsibilities and has more than one mission in the determination of the aptitude to driving. The evaluation of the aptitude of the (future) driver is based on different legal criteria (Belgian Royal Orders dated on 23-03-1998 and 05-09-2002) whose requirements are in accordance with EC reglementation and are different according as the motor vehicles are used for private or professional purposes. Social and psychological consequences of driving incapacity may be important as far as the real impact of vision alterations on the incidence of motor vehicle crashes is still to be clearly determined. The knowledge of the repercussions of different diseases such as ametropia, age related effects, loss of vision in one eye, cataract, glaucomatous neuropathy, laser treatments,... on car driving can help the ophthalmologist to improve his judgment on the patient's real driving aptitude and the quality of his counselling if needed.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
When prescribing drugs, the physician is responsible to warn his patient about potential impairment of driving capability. To do this, he needs to be aware of the duration and profile of actions, notably sedative and other effects affecting vigilance, cognitive and psychomotor functions. It is advisable to keep written records about such information. Impairment of driving capability may be more pronounced when ethanol is used during the action of drugs affecting central nervous function. The majority of published studies, particularly from epidemiological work with drivers, indicate an increased risk of accidents associated with the therapeutic use of benzodiazepines or cyclic antidepressants. Epidemiological data for other drugs available so far do not allow definite conclusions. Among antihistamines for drivers, loratadine or fexofenadine are probably preferable to ceritizine or older antihistamines. Patients with diabetes who drive should be informed about the risks and self-management of hypoglycaemia.
The risks of persons with controlled seizure disorders for traffic safety are reviewed. Previous studies provide insufficient and inaccurate data on this subject. Moreover, the advances in diagnosis and treatment of epilepsy and the improved safety and technology of automobiles and roads have made previous studies out of date and inapplicable to current circumstances. A number of vital questions concerning the determination of safe prognosis remain unanswered. Studies to address these questions and ways of improving future decision making are suggested.
Explore the source record for details and available documents.